web analytics

Hebrew U. Drug Trials Show 50% Cure Rate in Lab Mice Acute Leukemia

Leukemia cancer cells before and after treatment / Photo credit: Waleed Minzel / Hebrew University.


BioTheryX recently bought the rights to this promising drug from HU’s technology transfer company Yissum.

This content is for members only.

You must be logged in to access it.

Log In Register

Total Views: 24 ,